Everolimus Eluting Stent
Everolimus Eluting Stent is designed to reduce restenosis by releasing everolimus drug in a controlled manner after coronary angioplasty, ensuring long-term vessel patency.
Everolimus Eluting Stent is an advanced coronary stent used in interventional cardiology to treat narrowed or blocked arteries. It is coated with everolimus, an antiproliferative drug that helps prevent excessive tissue growth inside the artery, significantly reducing the risk of restenosis. The stent provides controlled and sustained drug release, supporting natural vessel healing while maintaining optimal blood flow. It is engineered for superior flexibility, smooth deliverability, and precise deployment, making it suitable for complex coronary interventions.
Advanced Features:
- Everolimus drug coating for anti-restenosis
- Controlled and sustained drug release
- High flexibility and radial strength
- Smooth trackability and accurate placement
- Biocompatible coating for enhanced healing
Product Also Known As:
Everolimus Stent, Drug Eluting Stent, Coronary DES, Cardiac Stent, Everolimus Coated Stent, PTCA Stent, Anti-Restenosis Stent
